UB Paderborn / Katalog / Suche / in CDI

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels

Journal of hepatology, 2022-05, Vol.76 (5), p.1042-1050

2022

Volltextzugriff (PDF)

Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study

Viruses, 2019-02, Vol.11 (2), p.186

2019

Volltextzugriff (PDF)

Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy

Open forum infectious diseases, 2020-02, Vol.7 (2), p.ofaa040

2020

Volltextzugriff (PDF)

Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B

Journal of hepatology, 2018-09, Vol.69 (3), p.584-593

2018

Volltextzugriff (PDF)

Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites

United European gastroenterology journal, 2020-06, Vol.8 (5), p.567-576

2020

Volltextzugriff (PDF)

New viral biomarkers for Hepatitis B: Are we able to change practice?

Journal of viral hepatitis, 2018-11, Vol.25 (11), p.1226-1235

2018

Volltextzugriff (PDF)

Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort

Clinical infectious diseases, 2016-03, Vol.62 (5), p.561-567

2016

Volltextzugriff (PDF)

Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B

The Journal of infectious diseases, 2016-11, Vol.214 (10), p.1492-1497

2016

Volltextzugriff (PDF)

What is new on HBsAg and other diagnostic markers in HBV infection?

Baillière's best practice & research. Clinical gastroenterology, 2017-06, Vol.31 (3), p.281-289

2017

Volltextzugriff (PDF)

Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg‐Negative CHB

Hepatology communications, 2021-01, Vol.5 (1), p.97-111

2021

Volltextzugriff (PDF)

Low anti‐HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen‐negative patients

Liver international, 2022-12, Vol.42 (12), p.2674-2682

2022

Volltextzugriff (PDF)

Duplicate prescriptions—proposal of a clinically oriented categorisation

European journal of clinical pharmacology, 2021-10, Vol.77 (10), p.1589-1591

2021

Volltextzugriff (PDF)

Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients

The Journal of infectious diseases, 2018-09, Vol.218 (9), p.1480-1484

2018

Volltextzugriff (PDF)

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens

Journal of hepatology, 2016-09, Vol.65 (3), p.473-482

2016

Volltextzugriff (PDF)

Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants

Clinical gastroenterology and hepatology, 2021-01, Vol.19 (1), p.46-60.e8

2021

Volltextzugriff (PDF)

Reply to Liaw

The Journal of infectious diseases, 2018-10, Vol.218 (11), p.1853-1854

2018

Volltextzugriff (PDF)

Concordance of emergency department physicians’ decisions on HIV post-exposure prophylaxis with national guidelines: results from a retrospective cohort study

International health, 2024-03, Vol.16 (2), p.219-226

2024

Volltextzugriff (PDF)

The role of HBsAg levels in the current management of chronic HBV infection

Annals of gastroenterology, 2014, Vol.27 (2), p.105-112

2014

Volltextzugriff (PDF)

Real‐world effect of ribavirin on quality of life in HCV‐infected patients receiving interferon‐free treatment

Liver international, 2018-05, Vol.38 (5), p.834-841

2018

Volltextzugriff (PDF)

Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany

BMC gastroenterology, 2021-07, Vol.21 (1), p.1-296, Article 296

2021

Volltextzugriff (PDF)

Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.1112-1113

2014

Volltextzugriff (PDF)

Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting

Liver international, 2015-07, Vol.35 (7), p.1845-1852

2015

Volltextzugriff (PDF)

HBsAg seroclearance with NUCs: rare but important

Gut, 2014-08, Vol.63 (8), p.1208-1209

2014

Volltextzugriff (PDF)

Automated low-flow ascites pump in a real-world setting: complications and outcomes

European journal of gastroenterology & hepatology, 2018-09, Vol.30 (9), p.1082-1089

2018

Volltextzugriff (PDF)

Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss

The Journal of infectious diseases, 2018-04, Vol.217 (10), p.1656-1666

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels

Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study

Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy

Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B

Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites

New viral biomarkers for Hepatitis B: Are we able to change practice?

Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort

Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B

What is new on HBsAg and other diagnostic markers in HBV infection?

Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg‐Negative CHB

Low anti‐HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen‐negative patients

Duplicate prescriptions—proposal of a clinically oriented categorisation

Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens

Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants

Reply to Liaw

Concordance of emergency department physicians’ decisions on HIV post-exposure prophylaxis with national guidelines: results from a retrospective cohort study

The role of HBsAg levels in the current management of chronic HBV infection

Real‐world effect of ribavirin on quality of life in HCV‐infected patients receiving interferon‐free treatment

Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany

Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection

Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting

HBsAg seroclearance with NUCs: rare but important

Automated low-flow ascites pump in a real-world setting: complications and outcomes

Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss

Suchergebnisse filtern